niraparib Capsules 100 mg
Dossier type
EU CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #10856
It is a pharmaceutical manufacturing company offering unique services covering a strategic base for the development of generics and ‘Day 1’ launch into the EU and beyond. Established in the 2000s, with a considerable investment of founding energy, expertise, and resources. The company boasts a state-of-the-art facility, infrastructure, and high-end equipment, dedicated to high potency ‘contained production’ to supply a range of therapeutic products for world markets.